Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Brainshuttle (BS) CD20-Multiple Sclerosis by Genentech USA for Multiple Sclerosis: Likelihood of Approval
Brainshuttle (BS) CD20-Multiple Sclerosis is under clinical development by Genentech USA and currently in Phase I for Multiple Sclerosis. According...